The list includes medications with unique pharmacokinetic properties, such as: Clinically, these drugs are primarily prescribed for the treatment of type 2 diabetes, but they also have additional benefits in obesity management, cardiovascular risk reduction, and, to some extent, fatty liver disease
The glucagon (GCGR) arm may be metabolically favorable for energy expenditure, but no trial has shown retatrutide directly builds or fully preserves muscle
Safety Profile and Side Effects Retatrutides side effect profile in Phase 2 trials was broadly consistent with other GLP-1 class therapies primarily gastrointestinal, primarily dose-dependent, and primarily manageable
Elevated blood glucose levels impair immune function, particularly the ability of white blood cells to identify and destroy bacteria
Up to 1500mg of ALCAR split into a couple of doses over the course of the day should be enough